Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Randal W. Scott,PhDN/A1,185,1173.59%2012-07-10
Steven Shak,M.D.Chief Scientific Officer327,2070.99%2016-06-21
Joffre B. Baker,PhDN/A132,8460.4%2012-02-15
Dr. Fred E. Cohen,M.D.,D.Phil.N/A64,5200.2%2016-04-01
Kimberly J. PopovitsN/A58,7960.18%2016-02-15
G. Bradley ColeCOO35,4260.11%2016-06-09
Mr. James J. VaughnChief Commercial Officer32,0790.1%2016-06-06
Mr. Frederic PlaN/A25,618less than 0.1%2016-02-15
Mr. Dean L. SchornoN/A24,524less than 0.1%2014-06-10
Brook H. ByersN/A23,951less than 0.1%2010-12-09

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.851.32327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.1-1.9235,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.92-6.7532,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.6138-5.434,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.01-4.0115,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$2856-6.7531,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.32.67326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.08-6.7524,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-18.766,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-17.6127,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-22.3624,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.04-10.7727,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.19-10.9812,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.66-10.9824,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.120.3130,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.98330,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.12-5.1630,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.96-0.530,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.16-5.1929,658 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2015-04-13Sell3,000203,001$31.2893.84-16.53Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.76-14.2229,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-18.18Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-1829,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.58-12.56Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-16.7721,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-18.236,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-21.97Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-20.85Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-19.7121,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-25.01Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-26.1422,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-27.956,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.34-15.17Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.08-9.2522,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.46-12.44Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.42-13.2322,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.2-4.57312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.210.15Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.77-1.81Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.22-3.4822,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$27189-3.3312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.11-2.32312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.30.04Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.48-5.4724,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.78-4.3222,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.62-1.62Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.364.0723,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.75-0.53311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$2781-3.322,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.52-7.93311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.28-5.9422,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.58-6.3515,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.66-4.64311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$2781-3.324,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-17.14308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-12.97Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.51-7.3118,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.98-11.7308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-14.9Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-21.4721,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-25.236,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-24.49Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-21.7321,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-16.7918,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.35-12308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-12.97Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.88-12.8218,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-22.59313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-23.9Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-19.7418,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-20.6421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-17.086,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-20.83318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-20.95Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-21.2421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-21.2421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-22.4319,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-26.1318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-24.56Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-22.7717,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-22.7717,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-21.6613,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-22.11323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-26.82Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-27.2317,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-27.79
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-28.4113,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-28.87
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-28.276,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-29.22
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-29.3
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-30.347,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-29.79327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-28.37
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-27.136,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-23.97
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-24.147,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-24.76Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-27.5117,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-27.4512,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-12.97Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.48-6.0512,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.43-8.6112,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.58-6.01
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.4-7.187,087 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.96-8.32
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.5-8.062,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.53-7.25
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.08-6.8514,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.54-9.256,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.5-6.7517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.7-6.3514,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.7-5.88333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.95-6.05Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$2884-6.7517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.68-6.216,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.12-2.68288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.26-2.936,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.7-3.08338,768 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.52-4.43288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.2-4.15Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.1-6.11288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$2884-6.7517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.55-8.7714,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-21.07Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-25.93343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-22.7317,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-22.7111,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-24.9714,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-22.66348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-17.61Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-25.4214,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-25.822,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-25.38353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-24.8Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.23-14.3714,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-27.276,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-23.74358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-24.88Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-26.22Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-27.3714,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-21.47363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-21.73Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-21.73Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-22.15Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-23.1413,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-22.75367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-19.06
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-20.9526,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-22.93
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-23.72Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-22.517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.04-12.85
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-13.6Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.18-9.5613,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.69-8.22
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.42-7.446,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.65-6.52372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.95-6.05Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.98-6.6818,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.8-8.67Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-13.7713,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-13.2377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-13.17Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-13.17Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-13.2377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-15.9919,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-15.91Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.85-12.7913,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.74-13.28
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.09-13.28
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.09-13.28
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-12.41
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.37-12.41
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.01-12.41
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.19-10.15
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.6-10.15
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.71-10.15
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.5285-8.39Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.38-6.95
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.8-6.95
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.1-6.95
1,419,381 (Through Partnership)
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.7-7.21382,849 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.65-11.01
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.85-11.1
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.34-11.1
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.71-9.2120,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.76-9.2120,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.24-0.95
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.09-0.95
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.13-0.95
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.6-0.27Link
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.6-0.27Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.18-1.3614,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.02-5.096,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.1-1.17Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.1-1.92Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.7-2.36382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$2828-6.7517,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.85-5.197,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.2-4.92Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.150.31387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.8-4.32Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.48-8.677,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.63-7.15
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.72-5.6
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.16-7.15
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.310.77
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.160.66
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.780.77
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.350.15392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.98-5.77
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.66-5.77
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.53-4.53
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.19-4.11
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.48-4.11
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.8-4.15Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.52-2.54
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.5-1.847,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.740.66
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.490.66
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.946.66
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1618.256,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.819.99392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.614.37Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5517.037,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.225.47Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.218.257,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.113.42392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.86.83Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.153.377,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.153.377,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.9-1.296,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.05-5.43392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.2-4.571,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.7-5.887,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.6-3.72392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.910.7718,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.81.631,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.12-0.31
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.92-0.31
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.68-0.34
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.45-0.277,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.61-4.5
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.06-4.53
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.3-4.53
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.752.19392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.48-1.419,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.2-2.06Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.830.697,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.080.27Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.92.88Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.922.43Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.323.12Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.20.58Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.55-2.97Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.256.79Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.799.75Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.327.49Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.327.49Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.41.91Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.380.31Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.784.19Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.124.19Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.083.49Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.442.59Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.061.63Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.71.63Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9211.63Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2111.63Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3512.2Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5115.99Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0815.99Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244417.61Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.223.45Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.223.45Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8723.98Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.620.16Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6517.98Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6814.97Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.216.25Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.615.33Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514049.2Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.144.73Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.442.91Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.9527987.17Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.7872.91Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.475.59Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.5373.95Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.1576.3Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.9276.3Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.6480.57Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.1380.57Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.0781.7Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.7381.7Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.8179.82Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.379.82Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.9474.18Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.6174.18Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.5673.26Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.4275.82Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.7675.82Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.574.07Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.277.5Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.5878.71Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.2378.71Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.2877.02Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2103.83Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41100.08Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.1528384.52Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.0485.84Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2465.46Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6864.52Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.267.26Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.868.34Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.454.77Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.554.5Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1454.68Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538934.24Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338635.28Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4834.66Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3234.24Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7931.67Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1553.14Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7953.14Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.651.54Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7849.11Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5253.5Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9453.5Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3452.33Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2551.36Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8749.46Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.629.77Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9528.05Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8427.86Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8829Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7828.87Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.235.92Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3330.29Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8830.62Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5830.55Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2526.44Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.127.86Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9226.38Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179823.33Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6523.57Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6525.95Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0426.32Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1429.77Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8525.71Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7430.68Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2730.68Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6830.68Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9130.68Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6533.69Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010030.55Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4433.97Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8833.9Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.833.97Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8833.97Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0434.45Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1734.03Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1163.09
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1163.09
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6242.91
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8947.6
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199537.42
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9145.3
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6245.3
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8145.3
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4545.3
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.629.77
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5234.17
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7233.55
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.133.55
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4633.55
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8233.55
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2832.4
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.642.51
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.973.32
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.834.59
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5536.49
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.621.33
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3626.75
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3626.75
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.225.23
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8534.52
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0229.45
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1135.64
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1135.64
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.841.9
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9831.4
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9831.4
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.630.22
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.729.45
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3228.24
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.415.99
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3515.17
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4819.83
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6513.87
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0315.07
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0810.31
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.246067.71
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.129.89
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125224.33
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1535.57
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20230.55
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0431.07
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7731.14
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4631.14
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0531.14
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2845.14
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522539.25
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.235.5
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6451.63
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0838.59
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.827.49
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1529.07
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2215.63
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1213.47
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1913.82
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.482.23
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8915.23
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9313.03
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4118.68
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8413.18
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4412.49
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9229.51
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8431.6
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2832.61
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.432.54
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5933.42
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3739.18
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9231.14
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9934.31
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1623.28
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018837.35
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9236.27
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2948.69
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8959.99
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8759.99
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.159.99
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0959.99
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7757.38
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6657.38
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.957.38
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6257.38
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9568.45
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6168.45
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0268.45
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.668.45
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8468.45
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9568.45
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4457.1
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.560.09
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2451.19
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4352.16
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1542.83
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8742.83
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.342.83
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2842.83
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2642.83
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.242.29
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1544.33
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8844.33
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.444.25
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0944.33
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4144.33
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1643.62
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2633.01
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1440.83
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.240.83
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7340.83
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0440.83
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0440.83
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5743.07
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5643.07
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0443.07
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6743.07
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5543.07
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4444.09
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8137.64
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8520.99
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4520.99
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1720.99
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0720.99
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.718.84
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3826.75
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8826.75
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1326.75
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2626.75
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.7285.84Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.2185.84Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.1785.84Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79117.58Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21117.58Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK